Feedback
Antimicrobial Susceptibility - Nocardia
0060193
Ordering Recommendation

Determine in vitro susceptibility to antimicrobial agents for Nocardia spp. and other aerobic actinomycetes.

Mnemonic
MA NOC
Methodology
Broth Microdilution
Performed
Sun-Sat
Reported
3-6 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Actively growing Nocardia isolate in pure culture. 
Specimen Preparation
Transport sealed container with isolate in pure culture on agar slant.  Place each specimen in individually sealed bag. 
Storage/Transport Temperature
Room temperature. 
Unacceptable Conditions
Mixed cultures or non-viable organisms. 
Remarks
Isolate identification and specimen source required. 
Stability
Ambient: 1 month; Refrigerated: 2 weeks; Frozen: Unacceptable 
Reference Interval
Susceptible, intermediate, or resistant.
Interpretive Data
Susceptibility testing is performed by broth microdilution using custom-made MIC panels and interpreted according to CLSI guidelines.

Note
The following agents are available for testing: amikacin, amoxicillin/clavulanic acid, cefepime, ceftriaxone, ciprofloxacin, clarithromycin, doxycycline, imipenem, linezolid, minocycline, moxifloxacin, tigecycline, tobramycin, and trimethoprim/sulfamethoxazole. Selective reporting by organism.

An additional processing fee will be billed for all organisms not submitted in pure culture, as indicated in the specimen requirements.

If species identification is not provided, identification will be performed at ARUP. Additional charges apply.
CPT Code(s)
87186
Components
Component Test Code*Component Chart NameLOINC
0060193Susceptibility, Nocardia29576-6
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Actinomycetes
  • Antimicrobial Susceptibility, Nocardia species
  • Nocardia Susceptibility Panel